[Federal Register Volume 84, Number 171 (Wednesday, September 4, 2019)]
[Notices]
[Pages 46549-46550]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-19201]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the National Vaccine Advisory Committee
AGENCY: Department of Health and Human Services, Office of the
Secretary, Office of the Assistant Secretary for Health, Office of
Infectious Disease Policy.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services is hereby giving notice that a
meeting is scheduled to be held for the National Vaccine Advisory
Committee (NVAC). The meeting will be open to the public; public
comment sessions will be held during the meeting.
DATES: The meeting will be held on September 17 and 18, 2019. The
meeting times and agenda will be posted on the NVAC website at https://www.hhs.gov/vaccines/nvac/meetings/index.html as soon as they become
available.
ADDRESSES: U.S. Department of Health and Human Services, Hubert H.
Humphrey Building, The Great Hall, 200 Independence Avenue SW,
Washington, DC 20201.
The meeting can also be accessed through a live webcast on both
days of the meeting. For more information, visit https://www.hhs.gov/webforms/nvac/index.html.
Pre-registration is required for members of the public who wish to
attend the meeting and who wish to participate in a public comment
session. Individuals who wish to attend the meeting and/or participate
in a public comment session should register at https://www.hhs.gov/webforms/nvac/index.html. Participants may also register by emailing
[email protected] or by calling (202) 795-7697 and providing their name,
organization, and email address.
FOR FURTHER INFORMATION CONTACT: Ann Aikin, Acting Designated Federal
Officer, Office of Infectious Disease Policy, U.S. Department of Health
and Human Services, Room L001, Switzer Building, 330 C Street SW,
Washington, DC 20201. Phone: (202) 795-7697; email: [email protected].
SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and
Human Services was mandated to establish the National Vaccine Program
to achieve optimal prevention of human infectious diseases through
immunization and to achieve
[[Page 46550]]
optimal prevention against adverse reactions to vaccines. The NVAC was
established to provide advice and make recommendations to the Director
of the National Vaccine Program on matters related to the Program's
responsibilities. The Assistant Secretary for Health serves as Director
of the National Vaccine Program.
During the September 2019 NVAC meeting, sessions will consist of
presentations on immunization equity, immunity, vaccines for small
populations and uncommon diseases, and influenza safety monitoring, and
evidence-based tools for improving influenza vaccination efforts.
Please note that agenda items will be related to the charges of the
Committee and are subject to change as priorities dictate. Information
on the final meeting agenda will be posted prior to the meeting on the
NVAC website: https://www.hhs.gov/vaccines/nvac/meetings/index.html.
Public attendance at the meeting is limited to the available space.
Individuals who plan to attend in person and need special assistance,
such as sign language interpretation or other reasonable
accommodations, should notify the Office of Infectious Disease Policy
at the address/phone number listed above at least one week prior to the
meeting. For those unable to attend in person, a live webcast will be
available. More information on registration and accessing the webcast
can be found at https://www.hhs.gov/vaccines/nvac/meetings/index.html.
Members of the public will have the opportunity to provide comments
at the NVAC meeting during the public comment periods designated on the
agenda. Public comments made during the meeting will be limited to
three minutes per person to ensure time is allotted for all those
wishing to speak. Individuals are also welcome to submit their written
comments. Written comments should not exceed three pages in length.
Individuals submitting written comments should email their comments to
the Office of Infectious Disease Policy ([email protected]) at least five
business days prior to the meeting.
Dated: August 16, 2019.
Ann Aikin,
Acting Designated Federal Officer, Office of Infectious Disease and
HIV/AIDS Policy.
[FR Doc. 2019-19201 Filed 9-3-19; 8:45 am]
BILLING CODE 4150-44-P